Kyorin Pharmaceutical Co., Ltd.

Kyorin Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company specializing in the research, development, manufacturing, and sale of ethical, generic, and over-the-counter drugs. Founded in 1923 and headquartered in Tokyo, Kyorin's primary mission is to address unmet medical needs through drug discovery and the development of high-value pharmaceuticals that improve patient health outcomes. The company’s portfolio includes new drugs, in-licensed products, diagnostic reagents, and solutions for infectious diseases, marketed under established brands such as Kipres, Mucodyne, Pentasa, and others. Kyorin’s business also encompasses contract manufacturing, ensuring a stable supply of reliable pharmaceutical products. In addition to its strong R&D pipeline, Kyorin is active in forming strategic alliances and licensing agreements to enhance its global presence. Its commitment to quality assurance, regulatory compliance, and corporate responsibility positions Kyorin as a significant player within the healthcare and life sciences sector, contributing to advancements in pharmaceutical therapies and public health initiatives in Japan and beyond.